Quadrant Private Equity is re-entering the rapidly corporatising cancer care segment with plans to invest $100 million to become the largest shareholder in the privately owned CancerCare Partners in the next two years.
CancerCare founder and CEO Tony Noun, left, and Marcus Darville of Quadrant Private Equity, which is set to become CancerCare’s largest shareholder.Quadrant’s Marcus Darville said he hoped the partnership with CancerCare Partners, which has three centres – in Sydney’s Miranda and Frenchs Forest, and Wagga Wagga – would create a third major player.
“We’re very attracted to the quality of the group and the strength of the doctors, the technical excellence and growth opportunities,” Mr Darville said.Tony Noun, founder, CEO and the largest existing investor in CancerCare Partners, said he was excited to partner with Quadrant and it was important for the group to remain Australian-owned.
“Our attitude and approach is about providing excellence in cancer care. You can’t do that if you are not involved in clinical research and clinical trials to ensure patients have access to the latest treatment protocols.